Astrana Health, Inc. Stock

Equities

ASTH

US03763A2078

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
39.05 USD +2.52% Intraday chart for Astrana Health, Inc. +5.34% +1.96%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 1.77B Sales 2025 * 2.13B Capitalization 1.81B
Net income 2024 * 74M Net income 2025 * 91M EV / Sales 2024 * 0.98 x
Net cash position 2024 * 77.7M Net cash position 2025 * 173M EV / Sales 2025 * 0.77 x
P/E ratio 2024 *
25.8 x
P/E ratio 2025 *
21.5 x
Employees 1,800
Yield 2024 *
0.33%
Yield 2025 *
0.41%
Free-Float 64.74%
More Fundamentals * Assessed data
Dynamic Chart
Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating MT
Transcript : Astrana Health, Inc., Q1 2024 Earnings Call, May 07, 2024
Earnings Flash (ASTH) ASTRANA HEALTH Posts Q1 Revenue $404.4M, vs. Street Est of $413.9M MT
Astrana Health, Inc. Reiterates Earnings Guidance for the Year Ending December 31, 2024 CI
Astrana Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Astrana Health, Inc. acquired PRIME COMMUNITY CARE OF CENTRAL VALLEY, INC. CI
Astrana Health, Inc. Announces Redesignation of Albert Young from Chief Administrative Officer to A New Role as Senior Vice President of Health Affairs CI
Astrana Health Completes Acquisition of Community Family Care Medical Group MT
Astrana Health Management, Inc. completed the acquisition of All Assets of Community Family Care Medical Group IPA. CI
Truist Securities Adjusts Price Target on Astrana Health to $44 From $41, Maintains Hold Rating MT
Transcript : Apollo Medical Holdings, Inc., Q4 2023 Earnings Call, Feb 27, 2024
Astrana Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024 CI
Astrana Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Jefferies Starts Coverage on Apollo Medical With Buy Rating MT
Apollo Medical Holdings, Inc. will Change its Ticker to ASTH from AMEH CI
More news
1 day+2.52%
1 week+5.34%
Current month+5.11%
1 month-8.25%
3 months+4.78%
6 months+28.24%
Current year+1.96%
More quotes
1 week
34.91
Extreme 34.91
39.32
1 month
34.91
Extreme 34.91
41.92
Current year
34.11
Extreme 34.11
45.71
1 year
28.87
Extreme 28.865
45.71
3 years
26.89
Extreme 26.89
133.23
5 years
9.27
Extreme 9.27
133.23
10 years
9.27
Extreme 9.27
133.23
More quotes
Managers TitleAgeSince
Founder 70 85-10-31
Chief Executive Officer 30 19-05-31
Founder 74 85-10-31
Members of the board TitleAgeSince
Director/Board Member 62 21-12-30
Director/Board Member 67 17-12-07
Director/Board Member 67 19-09-28
More insiders
Date Price Change Volume
24-05-08 38.09 +0.42% 158,669
24-05-07 37.93 -1.02% 125,527
24-05-06 38.32 +2.30% 106,286
24-05-03 37.46 +1.05% 106,977
24-05-02 37.07 -0.48% 114,734

Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT

More quotes
Astrana Health, Inc. is a healthcare company. The Company provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's Care Enablement segment is an integrated, end-to-end clinical and administrative platform, powered by its technology suite, which provides operational, clinical, financial, technology, management, and strategic services. Its Care Partners segment is focused on building and managing provider networks by partnering with provider partners for coordinated care delivery. Its Care Delivery segment is a data-driven care delivery organization focused on delivering accessible care to all patients. Its care delivery organization includes primary care, multi-specialty care, and ancillary care services.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
38.09 USD
Average target price
52.5 USD
Spread / Average Target
+37.83%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW